Rang	Name	Position
1	Mr. Wei Fu	Executive Chairman
2	Dr. Xi-Yong Fu M.B.A., Ph.D.	CEO & Director
3	Kyler Lei	Chief Financial Officer
4	Mr. Tyler Ehler	Senior Director of Investor Relations
5	Dr. Claire Xu M.D., Ph.D.	Senior Vice President of Clinical Development
6	Dr. Phillip Dennis M.D., Ph.D.	Chief Medical Officer
7	Mr. Sean Wuxiong Cao M.B.A., Ph.D.	Chief Business Development Officer & Independent Director

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Hillhouse Capital Advisors, Ltd.	7,32%	39,09 Mio. USD
2	Candriam Luxembourg S.C.A.	1,39%	7,40 Mio. USD
3	SG Americas Securities, LLC	1,07%	5,73 Mio. USD
4	Two Sigma Advisers, LLC	0,26%	1,37 Mio. USD
5	UBS Group AG	0,23%	1,21 Mio. USD
6	Aberdeen Group PLC	0,17%	0,89 Mio. USD
7	BNP Paribas Arbitrage, SA	0,15%	0,80 Mio. USD
8	Two Sigma Investments LLC	0,14%	0,74 Mio. USD
9	Ariose Capital Management Ltd	0,12%	0,63 Mio. USD
10	Alberta Investment Management Corp	0,09%	0,49 Mio. USD
11	Renaissance Technologies Corp	0,08%	0,42 Mio. USD
12	Dimensional Fund Advisors, Inc.	0,07%	0,38 Mio. USD
13	Morgan Stanley - Brokerage Accounts	0,07%	0,38 Mio. USD
14	Geode Capital Management, LLC	0,07%	0,36 Mio. USD
15	Susquehanna International Group, LLP	0,05%	0,25 Mio. USD
16	Change Path, LLC	0,05%	0,24 Mio. USD
17	Barclays PLC	0,04%	0,20 Mio. USD
18	Mariner Wealth Advisors LLC	0,04%	0,19 Mio. USD
19	Connor Clark & Lunn Inv Mgmt Ltd	0,03%	0,18 Mio. USD
20	HRT FINANCIAL LLC	0,03%	0,16 Mio. USD